US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 587.140
  • -11.620-1.94%
Trading May 1 15:51 ET
63.39BMarket Cap14.92P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-30.90%1.05B
-3.78%4.42B
15.89%1.26B
15.88%1.29B
-65.38%354M
10.60%1.51B
-8.39%4.59B
-36.64%1.09B
77.18%1.11B
81.15%1.02B
Net income from continuing operations
12.01%808.7M
11.61%4.41B
-20.86%917.7M
33.02%1.34B
47.90%1.43B
-11.71%722M
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
Operating gains losses
-171.34%-139.9M
-144.41%-118.3M
466.44%212.9M
-206.06%-134.7M
-1,370.55%-392.6M
17.71%196.1M
623.91%266.4M
27.92%-58.1M
150.10%127M
-81.43%30.9M
Depreciation and amortization
11.22%126.9M
14.70%482.9M
11.86%126.4M
15.46%121.7M
17.07%120.7M
14.67%114.1M
23.32%421M
12.89%113M
13.82%105.4M
38.58%103.1M
Deferred tax
26.94%-139.1M
9.61%-757.3M
2.13%-280.2M
-34.13%-168.6M
43.57%-118.1M
12.06%-190.4M
-12.25%-837.8M
-2.36%-286.3M
-46.67%-125.7M
-34.17%-209.3M
Other non cash items
3,100.00%3.2M
36,200.00%36.1M
488.57%68M
-145.76%-29M
-134.88%-3M
-99.51%100K
-100.02%-100K
-110.36%-17.5M
-119.44%-11.8M
-96.55%8.6M
Change In working capital
-70.58%129.6M
-557.07%-618.3M
-40.72%-86.4M
66.77%-63.9M
-1,017.47%-908.5M
82.86%440.5M
61.32%-94.1M
-116.07%-61.4M
71.18%-192.3M
89.59%-81.3M
-Change in receivables
47.22%657.8M
-63.52%-554M
-42.44%-117.8M
16.09%-388.9M
-18,200.00%-494.1M
112.66%446.8M
-147.87%-338.8M
-137.66%-82.7M
-19.80%-463.5M
99.16%-2.7M
-Change in inventory
2.25%-152.3M
-128.08%-619.7M
-148.84%-117.7M
-112.95%-164.4M
-81.08%-181.8M
-232.91%-155.8M
60.99%-271.7M
67.22%-47.3M
65.46%-77.2M
58.18%-100.4M
-Change in prepaid assets
-130.42%-179.5M
-239.30%-407.5M
-133.66%-55.3M
191.47%252M
-15,379.41%-526.3M
-1,316.36%-77.9M
19.18%-120.1M
778.61%164.3M
-327.31%-275.5M
98.60%-3.4M
-Change in payables and accrued expense
-293.76%-214.1M
22.80%735.1M
262.65%225.6M
-66.40%194.4M
415.37%204.6M
-7.14%110.5M
532.51%598.6M
-139.90%-138.7M
460.95%578.6M
152.72%39.7M
-Change in other working capital
-84.86%17.7M
501.06%227.8M
-149.30%-21.2M
-5.08%43M
714.48%89.1M
425.63%116.9M
16.98%37.9M
172.15%43M
355.93%45.3M
-114.47%-14.5M
Cash from discontinued investing activities
Operating cash flow
-30.90%1.05B
-3.78%4.42B
15.89%1.26B
15.88%1.29B
-65.38%354M
10.60%1.51B
-8.39%4.59B
-36.64%1.09B
77.18%1.11B
81.15%1.02B
Investing cash flow
Cash flow from continuing investing activities
138.38%647.5M
22.51%-2.47B
629.61%350.6M
-15.74%-574.4M
76.66%-557.2M
-615.78%-1.69B
15.84%-3.19B
96.44%-66.2M
-358.09%-496.3M
-476.69%-2.39B
Capital expenditure reported
-71.25%-229.3M
-5.19%-755.9M
20.60%-199.6M
-37.44%-241.9M
-59.73%-180.5M
24.86%-133.9M
-21.78%-718.6M
-65.18%-251.4M
-23.51%-176M
26.43%-113M
Net PPE purchase and sale
----
--20.1M
--0
--0
----
----
--0
--0
--0
----
Net intangibles purchase and sale
-51.25%-42.2M
39.51%-125.7M
-8.53%-67.4M
--0
-45.45%-30.4M
72.35%-27.9M
79.76%-207.8M
37.90%-62.1M
97.42%-23.9M
---20.9M
Net business purchase and sale
----
69.95%-16.5M
-202.63%-11.5M
--0
----
----
76.16%-54.9M
---3.8M
---51.1M
----
Net investment purchase and sale
160.25%919M
27.85%-1.59B
150.54%629.1M
-35.55%-332.5M
83.96%-361.4M
-3,614.52%-1.53B
-13.75%-2.2B
115.64%251.1M
-119.44%-245.3M
-7,410.00%-2.25B
Cash from discontinued investing activities
Investing cash flow
138.38%647.5M
22.51%-2.47B
629.61%350.6M
-15.74%-574.4M
76.66%-557.2M
-615.78%-1.69B
15.84%-3.19B
96.44%-66.2M
-358.09%-496.3M
-476.69%-2.39B
Financing cash flow
Cash flow from continuing financing activities
-2,412.53%-1.09B
-22.93%-2.2B
-154.54%-1.14B
-55.66%-634M
22.16%-478.1M
114.60%47.1M
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
Net common stock issuance
-2,191.51%-985.1M
-21.06%-2.17B
-154.54%-1.14B
-47.46%-600.6M
22.16%-478.1M
114.60%47.1M
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
Cash dividends paid
---93.8M
----
----
----
----
--0
----
----
----
----
Net other financing activities
---10.3M
---33.4M
--0
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-2,412.53%-1.09B
-22.93%-2.2B
-154.54%-1.14B
-55.66%-634M
22.16%-478.1M
114.60%47.1M
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
Net cash flow
Beginning cash position
-9.09%2.49B
-12.23%2.74B
-6.87%2.01B
-1.10%1.93B
-33.57%2.61B
-12.23%2.74B
7.64%3.12B
-38.36%2.16B
-42.80%1.95B
16.96%3.93B
Current changes in cash
573.25%603.4M
34.92%-248.1M
-17.23%477.9M
-60.70%82.8M
65.57%-681.3M
-115.75%-127.5M
-272.25%-381.2M
249.82%577.4M
119.02%210.7M
-4,105.47%-1.98B
Effect of exchange rate changes
220.00%600K
-75.00%-700K
-450.00%-700K
500.00%800K
25.00%-300K
---500K
---400K
--200K
---200K
---400K
End cash Position
18.51%3.09B
-9.09%2.49B
-9.09%2.49B
-6.87%2.01B
-1.10%1.93B
-33.57%2.61B
-12.23%2.74B
-12.23%2.74B
-38.36%2.16B
-42.80%1.95B
Free cash flow
-42.73%773.6M
-3.51%3.54B
28.29%995.8M
14.75%1.05B
-83.89%143.1M
24.09%1.35B
7.93%3.67B
-47.11%776.2M
307.63%914.4M
116.29%888.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -30.90%1.05B-3.78%4.42B15.89%1.26B15.88%1.29B-65.38%354M10.60%1.51B-8.39%4.59B-36.64%1.09B77.18%1.11B81.15%1.02B
Net income from continuing operations 12.01%808.7M11.61%4.41B-20.86%917.7M33.02%1.34B47.90%1.43B-11.71%722M-8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M
Operating gains losses -171.34%-139.9M-144.41%-118.3M466.44%212.9M-206.06%-134.7M-1,370.55%-392.6M17.71%196.1M623.91%266.4M27.92%-58.1M150.10%127M-81.43%30.9M
Depreciation and amortization 11.22%126.9M14.70%482.9M11.86%126.4M15.46%121.7M17.07%120.7M14.67%114.1M23.32%421M12.89%113M13.82%105.4M38.58%103.1M
Deferred tax 26.94%-139.1M9.61%-757.3M2.13%-280.2M-34.13%-168.6M43.57%-118.1M12.06%-190.4M-12.25%-837.8M-2.36%-286.3M-46.67%-125.7M-34.17%-209.3M
Other non cash items 3,100.00%3.2M36,200.00%36.1M488.57%68M-145.76%-29M-134.88%-3M-99.51%100K-100.02%-100K-110.36%-17.5M-119.44%-11.8M-96.55%8.6M
Change In working capital -70.58%129.6M-557.07%-618.3M-40.72%-86.4M66.77%-63.9M-1,017.47%-908.5M82.86%440.5M61.32%-94.1M-116.07%-61.4M71.18%-192.3M89.59%-81.3M
-Change in receivables 47.22%657.8M-63.52%-554M-42.44%-117.8M16.09%-388.9M-18,200.00%-494.1M112.66%446.8M-147.87%-338.8M-137.66%-82.7M-19.80%-463.5M99.16%-2.7M
-Change in inventory 2.25%-152.3M-128.08%-619.7M-148.84%-117.7M-112.95%-164.4M-81.08%-181.8M-232.91%-155.8M60.99%-271.7M67.22%-47.3M65.46%-77.2M58.18%-100.4M
-Change in prepaid assets -130.42%-179.5M-239.30%-407.5M-133.66%-55.3M191.47%252M-15,379.41%-526.3M-1,316.36%-77.9M19.18%-120.1M778.61%164.3M-327.31%-275.5M98.60%-3.4M
-Change in payables and accrued expense -293.76%-214.1M22.80%735.1M262.65%225.6M-66.40%194.4M415.37%204.6M-7.14%110.5M532.51%598.6M-139.90%-138.7M460.95%578.6M152.72%39.7M
-Change in other working capital -84.86%17.7M501.06%227.8M-149.30%-21.2M-5.08%43M714.48%89.1M425.63%116.9M16.98%37.9M172.15%43M355.93%45.3M-114.47%-14.5M
Cash from discontinued investing activities
Operating cash flow -30.90%1.05B-3.78%4.42B15.89%1.26B15.88%1.29B-65.38%354M10.60%1.51B-8.39%4.59B-36.64%1.09B77.18%1.11B81.15%1.02B
Investing cash flow
Cash flow from continuing investing activities 138.38%647.5M22.51%-2.47B629.61%350.6M-15.74%-574.4M76.66%-557.2M-615.78%-1.69B15.84%-3.19B96.44%-66.2M-358.09%-496.3M-476.69%-2.39B
Capital expenditure reported -71.25%-229.3M-5.19%-755.9M20.60%-199.6M-37.44%-241.9M-59.73%-180.5M24.86%-133.9M-21.78%-718.6M-65.18%-251.4M-23.51%-176M26.43%-113M
Net PPE purchase and sale ------20.1M--0--0----------0--0--0----
Net intangibles purchase and sale -51.25%-42.2M39.51%-125.7M-8.53%-67.4M--0-45.45%-30.4M72.35%-27.9M79.76%-207.8M37.90%-62.1M97.42%-23.9M---20.9M
Net business purchase and sale ----69.95%-16.5M-202.63%-11.5M--0--------76.16%-54.9M---3.8M---51.1M----
Net investment purchase and sale 160.25%919M27.85%-1.59B150.54%629.1M-35.55%-332.5M83.96%-361.4M-3,614.52%-1.53B-13.75%-2.2B115.64%251.1M-119.44%-245.3M-7,410.00%-2.25B
Cash from discontinued investing activities
Investing cash flow 138.38%647.5M22.51%-2.47B629.61%350.6M-15.74%-574.4M76.66%-557.2M-615.78%-1.69B15.84%-3.19B96.44%-66.2M-358.09%-496.3M-476.69%-2.39B
Financing cash flow
Cash flow from continuing financing activities -2,412.53%-1.09B-22.93%-2.2B-154.54%-1.14B-55.66%-634M22.16%-478.1M114.60%47.1M-77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M
Net common stock issuance -2,191.51%-985.1M-21.06%-2.17B-154.54%-1.14B-47.46%-600.6M22.16%-478.1M114.60%47.1M-77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M
Cash dividends paid ---93.8M------------------0----------------
Net other financing activities ---10.3M---33.4M--0----------------------------
Cash from discontinued financing activities
Financing cash flow -2,412.53%-1.09B-22.93%-2.2B-154.54%-1.14B-55.66%-634M22.16%-478.1M114.60%47.1M-77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M
Net cash flow
Beginning cash position -9.09%2.49B-12.23%2.74B-6.87%2.01B-1.10%1.93B-33.57%2.61B-12.23%2.74B7.64%3.12B-38.36%2.16B-42.80%1.95B16.96%3.93B
Current changes in cash 573.25%603.4M34.92%-248.1M-17.23%477.9M-60.70%82.8M65.57%-681.3M-115.75%-127.5M-272.25%-381.2M249.82%577.4M119.02%210.7M-4,105.47%-1.98B
Effect of exchange rate changes 220.00%600K-75.00%-700K-450.00%-700K500.00%800K25.00%-300K---500K---400K--200K---200K---400K
End cash Position 18.51%3.09B-9.09%2.49B-9.09%2.49B-6.87%2.01B-1.10%1.93B-33.57%2.61B-12.23%2.74B-12.23%2.74B-38.36%2.16B-42.80%1.95B
Free cash flow -42.73%773.6M-3.51%3.54B28.29%995.8M14.75%1.05B-83.89%143.1M24.09%1.35B7.93%3.67B-47.11%776.2M307.63%914.4M116.29%888.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.235
New Fortress Energy
NFE
5.735
Precision Drilling
PDS
43.001
4
Lantheus
LNTH
106.080
5
Cars.com
CARS
11.805
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.